Scholar Rock Holding Corporation (SRRK)
NASDAQ: SRRK · Real-Time Price · USD
37.70
-1.45 (-3.70%)
Feb 21, 2025, 4:00 PM EST - Market closed
Scholar Rock Holding Employees
Scholar Rock Holding had 150 employees as of December 31, 2023. The number of employees increased by 36 or 31.58% compared to the previous year.
Employees
150
Change (1Y)
36
Growth (1Y)
31.58%
Revenue / Employee
n/a
Profits / Employee
-$1,506,440
Market Cap
3.53B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
SRRK News
- 1 day ago - Scholar Rock to Present Additional Clinical Data from the Phase 3 SAPPHIRE Trial at the 2025 Muscular Dystrophy Association (MDA) Clinical & Scientific Conference - Business Wire
- 8 days ago - Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 12 days ago - Scholar Rock to Host Conference Call to Discuss Fourth Quarter and Full-Year 2024 Financial Results and Provide Business Update on February 27, 2025 - Business Wire
- 23 days ago - Scholar Rock: More Than Just An SMA Biotech With Q2 2025 Obesity Treatment Data - Seeking Alpha
- 24 days ago - Scholar Rock Submits Biologics License Application (BLA) to the U.S. FDA for Apitegromab as a Treatment for Patients with Spinal Muscular Atrophy (SMA) - Business Wire
- 24 days ago - Scholar Rock Announces the Appointment of Industry Leader Lisa Wyman as Chief Technical and Quality Officer and Planned Leadership Transition - Business Wire
- 5 weeks ago - Scholar Rock Sets Sights on $2 Billion Apitegromab Revenue Amid Spinal Muscular Atrophy Market Growth - Benzinga
- 6 weeks ago - Scholar Rock Highlights 2025 Strategic Priorities - Business Wire